These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31254610)

  • 1. ALS and FTD: Where RNA metabolism meets protein quality control.
    Mandrioli J; Mediani L; Alberti S; Carra S
    Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.
    Nedelsky NB; Taylor JP
    RNA; 2022 Jan; 28(1):97-113. PubMed ID: 34706979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration.
    Ito D; Hatano M; Suzuki N
    Sci Transl Med; 2017 Nov; 9(415):. PubMed ID: 29118263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
    Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
    Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
    Rayner SL; Cheng F; Hogan AL; Grima N; Yang S; Ke YD; Au CG; Morsch M; De Luca A; Davidson JM; Molloy MP; Shi B; Ittner LM; Blair I; Chung RS; Lee A
    Hum Mol Genet; 2021 May; 30(11):971-984. PubMed ID: 33729478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
    Deng Z; Sheehan P; Chen S; Yue Z
    Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
    Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
    Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
    Fecto F; Siddique T
    Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
    Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
    Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological implications of RNP granules in frontotemporal dementia and ALS.
    Desai P; Bandopadhyay R
    Neurochem Int; 2020 Nov; 140():104819. PubMed ID: 32763254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.
    Hayes LR; Kalab P
    Neurotherapeutics; 2022 Jul; 19(4):1061-1084. PubMed ID: 35790708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
    Davidson JM; Chung RS; Lee A
    Neurobiol Dis; 2022 May; 166():105653. PubMed ID: 35143965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.